Role of dual-site phospholamban phosphorylation in the stunned heart: Insights from phospholamban site-specific mutants

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 3 54-3, 2003, Pages

  Said, M ^a   Vittone, L ^a   Mundina Weilenmann C ^a   Ferrero, P ^a   Kranias, E G ^b   Mattiazzi, A ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Ischemia reperfusion; Phospholamban mutants; Phospholamban phosphorylation residues

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; MUTANT PROTEIN; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PHOSPHOLAMBAN; PROPRANOLOL; PROTEIN KINASE (CALCIUM,CALMODULIN) II;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE RELAXATION; HEART MUSCLE REPERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; STUNNED HEART MUSCLE; TRANSGENIC MOUSE;

EID: 0042358922     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00209.2003     Document Type: Article

References (43)

1. Bassani JWM, Yuan W, and Bers DM. Fractional SR Ca release is regulated by trigger Ca and SR content in cardiac myocytes. Am J Physiol Cell Physiol 268: C1313-C1319, 1995.
2. Bolli R and Marbán E. Molecular and cellular mechanism of myocardial stunning. Physiol Rev 79: 609-634, 1999.
3. Braunwald E and Kloner RA. The stunned myocardium: prolonged postischemic ventricular dysfunction. Circulation 66: 1146-1149, 1982.
4. Brittsan A and Kranias EG. Phospholamban and cardiac contractile function. J Mol Cell Cardiol 32: 2131-2139, 2000.
5. Carrozza JP Jr, Bentivenga LA, Williams CP, Kuntz RE, Grossman W, and Morgan JP. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ Res 71: 1334-1340, 1992.
6. 16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to β-agonists. J Biol Chem 275: 38938-38943, 2000.
7. Cross HR, Kranias EG, Murphy E, and Steenbergen C. Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO. Am J Physiol Heart Circ Physiol 284: H683-H690, 2003.
8. England PJ. The significance of phosphorylation of myosin light chains in heart. J Mol Cell Cardiol 16: 591-595, 1984.
9. 2+ responsiveness and altered diastolic function in intact ventricular muscle. Circ Res 76: 1036-1048, 1995.
10. Hain J, Onoue H, Mayrleitner M, Fleischer S, and Schindler H. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J Biol Chem 270: 2074-2081, 1995.
11. Harada K, Franklin A, Johnson RG, Grossman W, and Morgan JP. Acidemia and hypernatremia enhance postischemic recovery of excitation-contraction coupling. Circ Res 74: 1197-1209, 1994.
12. 2+-calmodulin-dependent protein kinases. J Biol Chem 259: 15587-15596, 1984.
13. Hoit BD, Khoury SF, Kranias EG, Ball N, and Walsh RA. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res 77: 632-637, 1995.
14. Hoque AN, Nasa Y, and Abiko Y. Cardioprotective effect of d-propranolol in ischemic-reperfused isolated rat hearts. Eur J Pharmacol 236: 269-277, 1993.
15. 2+ pump of sarcoplasmic reticulum. Nature 342: 90-92, 1989.
16. Kadambi VJ, Ball N, Kranias EG, Walsh RA, and Hoit BD. Modulation of force-frequency relation by phospholamban in genetically engineered mice. Am J Physiol Heart Circ Physiol 276: H2245-H2250, 1999.
17. nd Walsh RA, and Kranias EG. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest 97: 533-539, 1996.
18. 2+ handling. Circ Res 89: 831-837, 2001.
19. Kiriazis H and Kranias EG. Genetically engineered models with alterations in cardiac membrane calcium-handling proteins. Annu Rev Physiol 62: 321-351, 2000.
20. Kranias EG and Solaro RJ. Phosphorylation of troponin I and phospholamban during catecholamine stimulation of rabbit heart, Nature 298: 182-184, 1982.
21. Krause SM, Jacobus WE, Becker LC. Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic "stunned" myocardium. Circ Res 65: 526-530, 1989.
22. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 79: 950-961, 1987.
23. Limbruno U, Zucchi R, Ronca-Testoni S, Galbani P, Ronca G, and Mariani M. Sarcoplasmic reticulum function in the "stunned" myocardium. J Mol Cell Cardiol 21: 1063-1072, 1989.
24. Luo W, Chu G, Sato Y, Zhou Z, Kadambi VJ, and Kranias EG. Transgenic approaches to define the functional role of dual site phospholamban phosphorylation. J Biol Chem 273: 4734-4739, 1998.
25. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, and Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 75: 401-409, 1994.
26. MacGowan GA, Du C, Cowan DB, Stamm C, McGowan FX, Solaro RJ, Koretsky AP, and Del Nido PJ. Ischemic dysfunction in transgenic mice expressing troponin I lacking protein kinase C phosphorylation sites. Am J Physiol Heart Circ Physiol 280: H835-H843, 2001.
27. 5FBAPTA and nuclear magnetic resonance method as applied to the study of ischemia and reperfusion. Circ Res 66: 1255-1267, 1990.
28. Mattiazzi A, Garay A, and Cingolani HE. Critical evaluation of isometric indexes of relaxation in rat and cat papillary muscles and toad ventricular strips. J Mol Cell Cardiol 18: 749-758, 1986.
29. Mosca SM, Gelpi RJ, Milei J, Fernández Alonso G, and Cingolani HE. Is stunning prevented by ischemic preconditioning? Mol Cell Biochem 186: 123-129, 1998.
30. Mundiña-Weilenmann C, Vittone L, Ortale M, Chiappe de Cingolani G, and Mattiazzi A. Immunodetection of phosphorylation sites gives new insights into the mechanisms underlying phospholamban phosphorylation in the intact heart. J Biol Chem 271: 33561-33567, 1996.
31. 2+] during ischaemia and reperfusion. Eur Heart J 1, Suppl K: K18-K30, 1999.
32. Rapundalo ST, Briggs FN, and Feher JJ. Effects of ischemia on the isolation and function of canine cardiac sarcoplasmic reticulum. J Mol Cell Cardiol 18: 837-851, 1986.
33. Reiken S, Gaburjakova M, Guatimosim S, Gomez AM, D'Armiento J, Burkhoff D, Wang J, Vassort G, Lederer JW, and Marks AR. PKA phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts: role of phosphatases and response to isoproterenol. J Biol Chem 278: 444-453, 2003.
34. 17 residue of phospholamban is different at different levels of β-adrenergic stimulation. Pflügers Arch 444: 801-809, 2002.
35. Sperelakis N, Xiong Z, and Haddad G. Regulation of slow calcium channels of myocardial cells and vascular smooth muscle cells by cyclic nucleotides and phosphorylation. Mol Cell Biochem 140: 103-117, 1994.
36. 2+ pump and blocking of phospholamban phosphorylation and dephosphorylation by a phospholamban monoclonal antibody. J Biol Chem 261: 7018-7023, 1986.
37. Tada M and Toyofuku T. Molecular regulation of phospholamban function and expression. Trends Cardiovasc Med 8: 330-340, 1998.
38. Vittone L, Mundiña-Weilenmann C, Said M, Ferrero P, and Mattiazzi A. Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways. J Mol Cell Cardiol 34: 39-50, 2002.
39. Vittone L, Mundiña-Weilenmann C, Said M, and Mattiazzi A. Mechanisms involved in the acidosis enhancement of the isoproterenol-induced phosphorylation of phospholamban in the intact heart. J Biol Chem 273: 9804-9811, 1998.
40. 2+-ATPase in the intact beating rabbit heart. Biochem Biophys Res Commun 264: 241-246, 1999.
41. 1 adenosine receptor overexpression on sarcoplasmic reticulum function. Cardiovasc Res 53: 326-333, 2002.
42. Zucchi R, Ronca F, and Ronca-Testoni S. Modulation of sarcoplasmic reticulum function: a new strategy in cardioprotection? Pharmacol Ther 89: 47-65, 2001.
43. Zucchi R, Ronca-Testoni S, Di Napoli P, Yu G, Gallina S, Bosco G, Ronca G, Calafiore AM, Mariani M, and Barsotti A. Sarcoplasmic reticulum calcium uptake in human myocardium subjected to ischemia and reperfusion during cardiac surgery. J Mol Cell Cardiol 28: 1693-1701, 1996.